The US FDA has granted final approval for Teva Pharmaceutical Industries ANDA for polyethylene glycol 3350 NF for oral solution, 17 gram/scoopful.
Teva's Polyethylene Glycol 3350 NF for oral solution is the AB-rated generic equivalent of Braintree's Miralax for oral solution, a product indicated for the treatment of occasional constipation.
Total annual sales of Polyethylene Glycol 3350 NF for oral solution are approximately $153 million.